SCHEMBL25137117

SCHEMBL25137117

CC(C)(C)OC(=O)Nc1cc(O)nc(Cl)c1F

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 1/20 0.40
▸ CYP17A1 P05093 1/20 0.39
▸ MAPKAPK2 P49137 2/20 0.37
▸ LCK P06239 2/20 0.36
▸ SYK P43405 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ HSP90AB1 P08238 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ KCNQ4 P56696 1/20 0.35
▸ KCNQ5 Q9NR82 1/20 0.35
▸ AAK1 Q2M2I8 2/20 0.35
▸ P2RX3 P56373 1/20 0.35
▸ BRD9 Q9H8M2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27141821 0.89 ATR (0.42) ATRCYP17A1MAPKAPK2LCKSYK
SCHEMBL25136736 0.86 ATR (0.40) ATRCYP17A1MAPKAPK2LCKRXFP1
SCHEMBL25136697 0.85 ATR (0.40) ATRCYP17A1MAPKAPK2LCKRXFP1
SCHEMBL26709368 0.84 RXFP1 (0.40) ATRCYP17A1MAPKAPK2LCKRXFP1
SCHEMBL31323628 0.81 MAPKAPK2 (0.40) ATRCYP17A1MAPKAPK2LCKPOLB
SCHEMBL25136933 0.78 CYP17A1 (0.36) ATRCYP17A1MAPKAPK2LCKRXFP1
SCHEMBL25136815 0.78 ATR (0.40) ATRCYP17A1MAPKAPK2LCKSYK
SCHEMBL16069701 0.77 CYP17A1 (0.43) ATRCYP17A1LCKSYKRXFP1
SCHEMBL31018064 0.77 CYP17A1 (0.43) ATRCYP17A1LCKSYKRXFP1
SCHEMBL30313207 0.77 HSP90AA1 (0.44) ATRCYP17A1RXFP1HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023061463-A1 NOVEL PYRIMIDOPYRIDINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 广东东阳光药业有限公司 2023-04-20 — — WO disclosed
Send feedback